Stockscreener 앱 받기
18.23
1.35%
-0.25
시간 외 거래:
18.23
전일 마감가:
$18.48
열려 있는:
$18.51
하루 거래량:
76,343
Relative Volume:
0.27
시가총액:
$468.30M
수익:
-
순이익/손실:
$11.77M
주가수익비율:
31.51
EPS:
0.5785
순현금흐름:
$-19.23M
1주 성능:
-3.85%
1개월 성능:
+9.56%
6개월 성능:
+1.96%
1년 성능:
+23.93%
1일 변동 폭
$17.84
$18.64
1주일 범위
$17.84
$19.22
52주 변동 폭
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
명칭
Tourmaline Bio Inc
전화
646-481-9832
주소
27 WEST 24TH STREET, NEW YORK
TRML을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
18.23 | 487.05M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-15 | 개시 | Jefferies | Buy |
| 2023-12-04 | 재개 | H.C. Wainwright | Buy |
| 2023-11-17 | 개시 | Truist | Buy |
| 2023-10-31 | 개시 | Guggenheim | Buy |
| 2023-10-25 | 개시 | Piper Sandler | Overweight |
| 2022-10-20 | 개시 | H.C. Wainwright | Buy |
| 2022-07-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
모두보기
Tourmaline Bio Inc 주식(TRML)의 최신 뉴스
What drives Tourmaline Bio Inc. stock priceExplosive trading growth - Autocar Professional
Tourmaline Bio Inc. Stock Analysis and ForecastExceptional market positioning - PrintWeekIndia
What drives SuRo Capital Corp. stock priceRapid wealth multiplication - jammulinksnews.com
High Growth Stocks in India s Emerging Markets Trusted Market PredictionsRapid market gains - Autocar Professional
What drives NMTC stock priceRemarkable growth - jammulinksnews.com
What analysts say about Tourmaline Bio Inc. stockBreakthrough wealth creation - jammulinksnews.com
Is Tourmaline Bio Inc. a good long term investmentHigh-return market picks - jammulinksnews.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of “Buy” from Brokerages - Defense World
What analysts say about TACOU stockPowerful profit generation - Jammu Links News
Is Nuburu Inc. a good long term investmentFree Investment Case Studies - Jammu Links News
What drives Warrior Met Coal Inc. stock priceFree Daily Trading Room Entry - Jammu Links News
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
should you buy bull(mumu the bull erc)Free Top Growth Stock Recommendations - Newser
Why Tourmaline Bio Inc. stock attracts strong analyst attentionDouble Your Capital Alerts - Newser
How Tourmaline Bio Inc. stock performs during market volatilityFree Discussion Group - Newser
What makes Tourmaline Bio Inc. stock price move sharplyCarefully Curated High Return Stocks - Newser
What makes Universe Pharmaceuticals INC stock price move sharplyInsider Level Guidance - Newser
How Cross Country Healthcare Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
How Orange County Bancorp Inc. stock performs during market volatilityDouble Profit With Half Risk - Newser
What makes Synopsys Inc. stock price move sharplyPro Trader Stock Focus - Newser
Why XRLX stock attracts strong analyst attentionFree Stock Trading Signals - Newser
How KRON stock performs during market volatilityVerified Return Tips - Newser
How Cantor Equity Partners Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser
Graves Ophthalmopathy Market Set to Grow Substantially Through 2034, DelveInsight Projects | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited - Barchart.com
Avrupa Minerals (CVE:AVU) Trading 33.3% Higher – What’s Next? - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by California State Teachers Retirement System - Defense World
Cantor Fitzgerald Weighs in on Tourmaline Bio FY2026 Earnings - Defense World
Corrigendum: THE ROLE OF IL-6 IN THYROID EYE DISEASE: AN UPDATE ON EMERGING TREATMENTS - Frontiers
Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments - Frontiers
Two Sigma Investments LP Sells 21,904 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio Releases Updated Corporate Presentation - TipRanks
Tourmaline Bio Elects Directors and Ratifies Auditor - TipRanks
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by Bank of America Corp DE - Defense World
Nuveen Asset Management LLC Has $1.55 Million Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
BNP Paribas Financial Markets Reduces Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio Inc (TRML) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):